New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Selenium Expert to Present Research at Embria's SSW Executive Breakfast

CEDAR RAPIDS, IA, October 24, 2005 - Embria (TM) Health Sciences, manufacturer of natural ingredients for use in high-quality, human nutritional products, has invited published author Margaret P. Rayman, Ph.D., to speak on selenium and its role in human health at their executive breakfast meeting during the SupplySide West International Trade Show and Conference in Las Vegas, NV, November 9 - 11, 2005. Dr. Rayman will present her published research on selenium supplementation during her presentation, "The Role of Selenium in Fighting Cancer and Viral Infections," on Thursday, November 10, 2005 at the Venetian Hotel's Marco Polo Room 701. Breakfast will be served at 8:15 a.m. and the presentation will begin promptly at 8:30 a.m.

"Dr. Rayman is an international authority on selenium and we are honored to have her speak at our SupplySide West event," stated Paul Faganel, Embria Health Sciences president. "Her published research on the use of high-selenium yeast to raise selenium status is especially relevant to our exclusive organic selenium yeast ingredient, eXselen (TM), and can provide attendees with a solid scientific foundation for the need for such an ingredient."

eXselen is pure, all-natural and fully pasteurized. The selenium yeast growth process used in the manufacturing of eXselen produces high levels of selenomethionine, an organic form of selenium that rapidly metabolizes within the body to yield high bioavailability and retention. Additionally, beneficial B vitamins and glucans are found in the yeast used in the manufacturing of eXselen.

Margaret Rayman, Ph.D., has published numerous articles in peer-reviewed journals on a variety of topics relating to human nutrition, such as selenium status, cancer and preeclampsia. Dr. Rayman holds a degree in chemistry from Queen's University Belfast and a Ph.D. in inorganic biochemistry from Oxford¹s Somerville College. She was awarded postdoctoral fellowships at the London Institute of Cancer Research, Imperial College London and the University of Surrey in Guildford. Currently, Dr. Rayman is a high-ranking academic figure at the University of Surrey, where she is a Reader in Nutritional Medicine and Course Director of the Nutritional Medicine Program for the University's School of Biomedical and Molecular Sciences.

Embria Health Sciences combines science and nature to bring high-quality, research-based natural ingredients to the global human nutrition market.
Embria's key products are manufactured using a proprietary technology, which produces vital metabolites that deliver nutritional benefits and support increased bioavailability. This premier technology is based on a similar process pioneered by Embria's parent company, Diamond V (R) Mills, Inc., a leader in animal nutrition ingredients and fermented yeast products since 1943, which has set the standard in the animal nutrition industry for more than 60 years.

For more information on the Embria's executive breakfast, or to arrange an interview with Dr. Rayman or Paul Faganel, please contact Amanda Holty at 801.538.0777 ext. 106, [email protected].

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.